Insider · CIK 0001417326
Lionel F. Conacher
directorceoofficer
Files at DXLG (DESTINATION XL GROUP, INC.), SRXH (SRx Health Solutions, Inc.). First filing Dec 26, 2024, latest Dec 26, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$227k bought, $1,086 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | SRXHbuy SRx Health Solutions, Inc. | $227k 30,463 shares | +450% | - | |
| 15Weak | SRXHsell SRx Health Solutions, Inc. | $1,086 635 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 12, 2026 | DXLG DESTINATION XL GROUP, INC. | AGrant or award Common Stock, $0.01 par value | +23,437 | $0.64 | $15k | 461,676 | 27 d ago |
| Feb 2, 2026 | DXLG DESTINATION XL GROUP, INC. | AGrant or award Common Stock, $0.01 par value | +29,648 | $0.68 | $20k | 375,960 | Feb 4, 2026 |
| Nov 3, 2025 | DXLG DESTINATION XL GROUP, INC. | AGrant or award Common Stock, $0.01 par value | +20,266 | $1.00 | $20k | 346,312 | Nov 5, 2025 |
| May 5, 2025 | DXLG DESTINATION XL GROUP, INC. | AGrant or award Common Stock, $0.01 par value | +17,307 | $1.17 | $20k | 326,046 | May 7, 2025 |
| Dec 23, 2024 | SRXH SRx Health Solutions, Inc. | SOpen-market sale Common Stock | -635 | $1.71 | $1,086 | 36,597 | Dec 26, 2024 |
| Nov 20, 2024 | SRXH SRx Health Solutions, Inc. | POpen-market purchase Common Stock | +5,000 | $1.71 | $8,550 | 37,232 | Dec 26, 2024 |
| Feb 1, 2024 | SRXH SRx Health Solutions, Inc. | POpen-market purchase Common Stock | +8,418 | $11.88 | $100k | 32,232 | Dec 26, 2024 |
| Sep 5, 2023 | SRXH SRx Health Solutions, Inc. | POpen-market purchase Common Stock | +17,045 | $6.97 | $119k | 23,814 | Dec 26, 2024 |
| Jun 26, 2024 | SRXH SRx Health Solutions, Inc. | POpen-market purchase Stock Options - Right to Buyderivative | +0 | $5.00 | $0 | 5,200 | Dec 26, 2024 |
| Sep 28, 2021 | SRXH SRx Health Solutions, Inc. | POpen-market purchase Stock Options - Right to Buyderivative | +0 | $159.28 | $0 | 615 | Dec 26, 2024 |
| Nov 20, 2024 | SRXH SRx Health Solutions, Inc. | AGrant or award Common Stock | +5,000 | $1.78 | $8,900 | 37,232 | Nov 27, 2024 |
| Feb 1, 2024 | SRXH SRx Health Solutions, Inc. | AGrant or award Common Stock | +8,418 | $0.27 | $2,273 | 32,642 | Nov 27, 2024 |
| Sep 5, 2023 | SRXH SRx Health Solutions, Inc. | AGrant or award Common Stock | +17,045 | $0.00 | $0 | 24,224 | Nov 27, 2024 |
| Jun 26, 2024 | SRXH SRx Health Solutions, Inc. | AGrant or award Stock Options - Right to Buyderivative | +0 | $5.00 | $0 | 5,200 | Nov 27, 2024 |
| Sep 28, 2021 | SRXH SRx Health Solutions, Inc. | AGrant or award Stock Options - Right to Buyderivative | +0 | $3.62 | $0 | 615 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.